Page last updated: 2024-08-17

methylene blue and Injury, Myocardial Reperfusion

methylene blue has been researched along with Injury, Myocardial Reperfusion in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horimoto, H; Mieno, S; Nomura, Y; Okawa, H; Shinjiro, S; Yoshida, M1
Bland-Ward, P; Curtis, MJ; Moore, PK; Pabla, R1
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T1
Akula, A; Kota, MK; Potharaju, S; Veeravalli, KK1

Other Studies

4 other study(ies) available for methylene blue and Injury, Myocardial Reperfusion

ArticleYear
Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts.
    Molecular and cellular biochemistry, 2003, Volume: 248, Issue:1-2

    Topics: Adenosine Triphosphate; Alkaloids; Animals; Atrial Natriuretic Factor; Benzophenanthridines; Cyclic GMP; Enzyme Inhibitors; Heart; Ischemia; Ischemic Preconditioning, Myocardial; Methylene Blue; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Reperfusion; Time Factors; Tissue Distribution

2003
An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart.
    British journal of pharmacology, 1995, Volume: 116, Issue:7

    Topics: Animals; Cyclic GMP; Disease Susceptibility; Electrocardiography; Hemodynamics; In Vitro Techniques; Male; Methylene Blue; Myocardial Reperfusion Injury; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Purinones; Rats; Rats, Wistar; Ventricular Fibrillation

1995
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Circulation, 1999, Feb-16, Volume: 99, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles

1999
Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin.
    Die Pharmazie, 2002, Volume: 57, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Bradykinin; Female; Heart Ventricles; Lisinopril; Male; Mercaptoethanol; Methylene Blue; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Nitric Oxide; Prostaglandin Antagonists; Rats; Rats, Wistar; Signal Transduction

2002